See also this year's filing and all EDGAR filings for this company.
PDF Report 0001739426_2020_RVL_Pharmaceuticals_plc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001739426, RVL Pharmaceuticals plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 172,630,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 254,841,000 |
| 2 | PropertyPlantAndEquipmentNet | 30,238,000 |
| 3 | remainder_Assets | 5,546,000 |
| 4 | LiabilitiesCurrent | 75,937,000 |
| 5 | LiabilitiesNoncurrent | 271,066,000 |
| 6 | remainder_Liabilities | 1,544,000 |
| 7 | CostOfGoodsAndServicesSold | 111,630,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 93,030,000 |
| 9 | ResearchAndDevelopmentExpense | 32,319,000 |
| 10 | remainder_Expenses | 256,626,000 |
| 11 | remainder_Revenues | 240,031,000 |
| 12 | remainder_NetIncome | -17,327,000 |
| 13 | remainder_ComprehensiveNetIncome | -383,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 463,255,000 |
| 1 | Liabilities | 348,547,000 |
| 2 | Expenses | 493,605,000 |
| 3 | Revenues | 240,031,000 |
| 4 | StockholdersEquity | 114,708,000 |
| 5 | NetIncome | -270,901,000 |
| 6 | ComprehensiveNetIncome | -271,092,500 |
| 7 | BaseVar | 781,574,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.0518 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
